Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 10 de 10
Filter
Add more filters










Publication year range
1.
Urology ; 165: 359-365, 2022 07.
Article in English | MEDLINE | ID: mdl-35461919

ABSTRACT

OBJECTIVE: To investigate a novel transurethral hemostatic catheter device with an integrated chitosan endoluminal hemostatic dressing (CEHD). Development and implementation of this technology may help address bleeding following surgery such as transurethral resection of prostate (TURP). Bleeding remains the most common complication following TURP, leading to increased morbidity and hospitalization. METHODS: Investigation of hemostasis, delivery, safety and efficacy of the CEHD device is conducted using Female Yorkshire swine (N = 23). Hemostatic efficacy of the CEHD (N = 12) is investigated against a control of gauze (N = 12) in a splenic injury model (3 swine). The delivery, safety, and efficacy of the CEHD device (N = 10) are investigated against Foley-catheter control (N = 10) for 7 days using a swine bladder-neck-injury model. RESULTS: In the splenic injury study, 9/12 CEHD dressings successfully achieved hemostasis within 150 seconds (mean 83 seconds) vs success of 6/12 (mean 150 seconds) for gauze (P = .04). In the 7-day study, the CEHD was successfully deployed in 10/10 animals and all dressings were tolerated without histologic or clinical adverse effect. Hemostasis of the CEHD device was found to be noninferior to control catheters. Noninferiority is attributed to low bleeding rates in the swine bladder neck injury model. CONCLUSION: This investigation successfully demonstrated the feasibility of transurethral deployment of the CEHD in vivo. Routine use of safe and slowly dissolvable CEHDs could reduce the rate of complications and hospitalizations associated with bleeding and blood loss in TURP procedures. Further investigation is warranted.


Subject(s)
Hemostatics , Prostatic Hyperplasia , Transurethral Resection of Prostate , Animals , Female , Hemorrhage/complications , Hemorrhage/prevention & control , Hemostasis , Hemostatics/therapeutic use , Humans , Male , Prostate , Prostatic Hyperplasia/surgery , Swine , Transurethral Resection of Prostate/methods , Urinary Catheters
2.
Waste Manag Res ; 40(7): 905-918, 2022 Jul.
Article in English | MEDLINE | ID: mdl-34802336

ABSTRACT

The UK recycling rate fluctuates between 45% and 47% and has consistently failed to meet the 65% target set by the post-Brexit Resource and Waste Strategy. Understanding the issues surrounding the low recycling rate in metropolitan cities in the United Kingdom will help to overcome these recycling challenges. The review examines the current situation with regard to the recycling rate and tonnage of waste produced in the United Kingdom based on available secondary waste flow data and explores different barriers related to household recycling. Many areas giving rise to the recycling challenges have been identified, including waste policy constraints, lack of effective communication, public engagement, physical barriers, service constraints, human factors and socio-economic barriers. The literature review reveals that factors such as waste policy, communication and physical factors were the most important aspects in influencing recycling rate or output. It is concluded that a multi-dimension intervention is required, which includes a thorough review of waste policy, a more stringent enforcement, an improved communication strategy and a more integrated planning development policy to mitigate issues affecting the United Kingdom's low recycling rate or output. This approach will propel the local authorities to launch or initiate effective recycling management and to put in place the required infrastructure to facilitate effective recycling activities.


Subject(s)
Refuse Disposal , Waste Management , Cities , European Union , Humans , Recycling/methods , Solid Waste/analysis , United Kingdom , Waste Management/methods
3.
J Flood Risk Manag ; 14(2): e12700, 2021 Jun.
Article in English | MEDLINE | ID: mdl-34899978

ABSTRACT

There has been a move towards a more integrated approach to flood risk management, which includes a stronger focus on property level measures. However, in England the uptake of these measures remains low. Flood experience has been found to influence preparedness (i.e., the uptake of measures), but even experience does not always result in an increase in preparedness. We investigate the variations in the relationship between experience and preparedness for the regions of England as defined by the Environment Agency. Analysis of survey data collected by the Environment Agency among the at risk population between 1997 and 2004 was undertaken to determine the differences between the seven regions. We find that in the South West, Southern and Anglian regions increases in preparedness with increasing experience are higher compared to other regions. In the Thames, Midlands and North West regions the preparedness increases less with increasing experience. We explore the influence of other factors influencing flood mitigation behaviour that have been previously found in the literature and find that the differences between regions are correlated with the severity of experienced flooding and whether English is the first language of the respondents.

4.
ACS Appl Mater Interfaces ; 11(1): 356-372, 2019 Jan 09.
Article in English | MEDLINE | ID: mdl-30516370

ABSTRACT

Magnetic electrospun fibers are of interest for minimally invasive biomaterial applications that also strive to provide cell guidance. Magnetic electrospun fibers can be injected and then magnetically positioned in situ, and the aligned fiber scaffolds provide consistent topographical guidance to cells. In this study, magnetically responsive aligned poly-l-lactic acid electrospun fiber scaffolds were developed and tested for neural applications. Incorporating oleic acid-coated iron oxide nanoparticles significantly increased neurite outgrowth, reduced the fiber alignment, and increased the surface nanotopography of the electrospun fibers. After verifying neuron viability on two-dimensional scaffolds, the system was tested as an injectable three-dimensional scaffold. Small conduits of aligned magnetic fibers were easily injected in a collagen or fibrinogen hydrogel solution and repositioned using an external magnetic field. The aligned magnetic fibers provided internal directional guidance to neurites within a three-dimensional collagen or fibrin model hydrogel, supplemented with Matrigel. Neurites growing from dorsal root ganglion explants extended 1.4-3× farther on the aligned fibers compared with neurites extending in the hydrogel alone. Overall, these results show that magnetic electrospun fiber scaffolds can be injected and manipulated with a magnetic field in situ to provide directional guidance to neurons inside an injectable hydrogel. Most importantly, this injectable guidance system increased both neurite alignment and neurite length within the hydrogel scaffold.


Subject(s)
Ganglia, Spinal/physiology , Hydrogels/chemistry , Nerve Regeneration , Neurites/metabolism , Tissue Scaffolds/chemistry , Animals , Ganglia, Spinal/cytology , Rats , Rats, Sprague-Dawley
5.
J Biol Chem ; 292(10): 4054-4063, 2017 03 10.
Article in English | MEDLINE | ID: mdl-28115521

ABSTRACT

Platelet factor 4 (PF4) is produced by platelets with roles in both inflammation and wound healing. PF4 is stored in platelet α-granules bound to the glycosaminoglycan (GAG) chains of serglycin. This study revealed that platelet serglycin is decorated with chondroitin/dermatan sulfate and that PF4 binds to these GAG chains. Additionally, PF4 had a higher affinity for endothelial-derived perlecan heparan sulfate chains than serglycin GAG chains. The binding of PF4 to perlecan was found to inhibit both FGF2 signaling and platelet activation. This study revealed additional insight into the ways in which PF4 interacts with components of the vasculature to modulate cellular events.


Subject(s)
Blood Platelets/metabolism , Chondroitin Sulfates/metabolism , Dermatan Sulfate/metabolism , Fibroblast Growth Factor 2/metabolism , Heparan Sulfate Proteoglycans/metabolism , Heparitin Sulfate/metabolism , Platelet Factor 4/metabolism , Proteoglycans/metabolism , Vesicular Transport Proteins/metabolism , Blotting, Western , Humans , Platelet Activation , Protein Binding
6.
Biomaterials ; 35(5): 1462-77, 2014 Feb.
Article in English | MEDLINE | ID: mdl-24246646

ABSTRACT

Implantation of a foreign material almost certainly results in the formation of a fibrous capsule around the implant however, mechanistic events leading to its formation are largely unexplored. Mast cells are an inflammatory cell type known to play a role in the response to material implants, through the release of pro-inflammatory proteases and cytokines from their α-granules following activation. This study examined the in vivo and in vitro response of mast cells to chitosan, through detection of markers known to be produced by mast cells or involved with the inflammatory response. Mast cells, identified as Leder stained positive cells, were shown to be present in response to material implants. Additionally, the mast cell receptor, c-kit, along with collagen, serglycin, perlecan and chondroitin sulphate were detected within the fibrous capsules, where distribution varied between material implants. In conjunction, rat mast cells (RBL-2H3) were shown to be activated following exposure to chitosan as indicated by the release of ß-hexosaminidase. Proteoglycan and glycosaminoglycans produced by the cells showed similar expression and localisation when in contact with chitosan to when chemically activated. These data support the role that mast cells play in the inflammatory host response to chitosan implants, where mediators released from their α-granules impact on the formation of a fibrous capsule by supporting the production and organisation of collagen fibres.


Subject(s)
Chitosan/administration & dosage , Mast Cells/cytology , Proteoglycans/metabolism , Animals , Cell Line , Chitosan/pharmacology , Female , Mast Cells/drug effects , Mast Cells/metabolism , Rats , Rats, Sprague-Dawley
7.
J Biomed Mater Res A ; 101(2): 340-8, 2013 Feb.
Article in English | MEDLINE | ID: mdl-22847951

ABSTRACT

Burns are a significant health challenge and healing can result in scar formation. Chitosan, a derivative of chitin, has been used to promote wound healing. In this study we used gene expression profiling in a mouse model of full thickness cutaneous burn to assess the benefits of treating with a chitosan lactate dressing. Three days after wounding mice treated with chitosan showed increased expression of genes associated with formation of granulation tissue. At a later time point, seven days after wounding, genes that initially showed increased expression were now down-regulated, and there was increased expression of genes involved in remodeling suggesting that the chitosan treatment results in accelerated healing. Quantitative RT-PCR showed modulated mRNA levels for TGFß1 by the chitosan dressing. TGFß1 initially promotes healing but extended activity can result in scarring. Importantly we found that expression was elevated at day three, but decreased at day seven suggesting that chitosan treatment will not result in scar formation, and may even be beneficial in preventing scar formation. Additionally, the biphasic regulation of expression of TGFß1 could be a powerful biomarker for future studies of the wound-healing potential of chitosan based and other treatments for burn wounds.


Subject(s)
Bandages , Burns/genetics , Chitosan/pharmacology , Gene Expression Profiling , Regeneration/drug effects , Signal Transduction/genetics , Wound Healing/drug effects , Animals , Burns/pathology , Down-Regulation/drug effects , Down-Regulation/genetics , Female , Fibrosis , Gene Regulatory Networks/drug effects , Mice , Mice, Inbred BALB C , RNA, Messenger/genetics , RNA, Messenger/metabolism , Regeneration/genetics , Reproducibility of Results , Up-Regulation/drug effects , Up-Regulation/genetics , Wound Healing/genetics
8.
J Biol Chem ; 288(5): 3289-304, 2013 Feb 01.
Article in English | MEDLINE | ID: mdl-23235151

ABSTRACT

Mast cells are derived from hematopoietic progenitors that are known to migrate to and reside within connective and mucosal tissues, where they differentiate and respond to various stimuli by releasing pro-inflammatory mediators, including histamine, growth factors, and proteases. This study demonstrated that primary human mast cells as well as the rat and human mast cell lines, RBL-2H3 and HMC-1, produce the heparan sulfate proteoglycan, perlecan, with a molecular mass of 640 kDa as well as smaller molecular mass species of 300 and 130 kDa. Utilizing domain-specific antibodies coupled with N-terminal sequencing, it was confirmed that both forms contained the C-terminal module of the protein core known as endorepellin, which were generated by mast cell-derived proteases. Domain-specific RT-PCR experiments demonstrated that transcripts corresponding to domains I and V, including endorepellin, were present; however, mRNA transcripts corresponding to regions of domain III were not present, suggesting that these cells were capable of producing spliced forms of the protein core. Fractions from mast cell cultures that were enriched for these fragments were shown to bind endothelial cells via the α(2)ß(1) integrin and stimulate the migration of cells in "scratch assays," both activities of which were inhibited by incubation with either anti-endorepellin or anti-perlecan antibodies. This study shows for the first time that mast cells secrete and process the extracellular proteoglycan perlecan into fragments containing the endorepellin C-terminal region that regulate angiogenesis and matrix turnover, which are both key events in wound healing.


Subject(s)
Heparan Sulfate Proteoglycans/metabolism , Mast Cells/metabolism , Neovascularization, Physiologic , Peptide Fragments/metabolism , Wound Healing , Amino Acid Sequence , Animals , Cell Adhesion , Cell Line , Cell Movement , Coronary Vessels/cytology , Endothelial Cells/cytology , Endothelial Cells/metabolism , Glycosaminoglycans/biosynthesis , Heparan Sulfate Proteoglycans/chemistry , Heparan Sulfate Proteoglycans/genetics , Heparan Sulfate Proteoglycans/isolation & purification , Humans , Integrin alpha2beta1/metabolism , Lung/cytology , Mast Cells/cytology , Molecular Sequence Data , Peptide Fragments/chemistry , Protein Isoforms/genetics , Protein Isoforms/metabolism , Protein Structure, Tertiary , Proteoglycans/biosynthesis , RNA, Messenger/genetics , RNA, Messenger/metabolism , Rats , Vesicular Transport Proteins/biosynthesis
9.
Biomaterials ; 32(28): 6655-62, 2011 Oct.
Article in English | MEDLINE | ID: mdl-21676458

ABSTRACT

Chitosan has been shown to promote initial wound closure events to prevent blood loss. Platelet adhesion and activation are crucial early events in these processes after traumatic bleeding leading to thrombus formation. Platelet adhesion to chitosan was found to be enhanced in the presence of adsorbed plasma and extracellular matrix proteins and was found to be primarily mediated by α(IIb)ß(3) integrins, while α(2)ß(1) integrins were found to be involved in platelet adhesion to collagen and perlecan. Platelets were found to be activated by chitosan, as shown by an increase in the expression of α(IIb)ß(3) integrins and P-selectin, while the extent of activation was modulated by the presence of proteins including perlecan and fibrinogen. Collagen-coated chitosan was found to activate platelets to the same extent as either chitosan or collagen alone. These data support the role of plasma and extracellular matrix proteins in promoting chitosan mediated platelet adhesion and activation supporting the hypothesis that chitosan promotes wound healing via these interactions.


Subject(s)
Blood Platelets/drug effects , Blood Platelets/physiology , Blood Proteins/metabolism , Chitosan/pharmacology , Extracellular Matrix Proteins/metabolism , Platelet Adhesiveness/drug effects , Adsorption , Humans , Wound Healing/drug effects
10.
J Trauma ; 54(1): 177-82, 2003 Jan.
Article in English | MEDLINE | ID: mdl-12544915

ABSTRACT

BACKGROUND: Hemorrhage is a leading cause of death from trauma. An advanced hemostatic dressing could augment available hemostatic methods. We studied the effects of a new chitosan dressing on blood loss, survival, and fluid use after severe hepatic injury in swine. METHODS: Swine received chitosan dressings or gauze sponges. Standardized, severe liver injuries were induced. After 30 seconds, dressings were applied and resuscitation initiated. Blood loss, hemostasis, resuscitation volume, and 60-minute survival were quantified. RESULTS: Posttreatment blood loss was reduced ( p< 0.01) in the chitosan group (264 mL; 95% confidence interval [CI], 82-852 mL) compared with the gauze group (2,879 mL; 95% CI, 788-10,513 mL). Fluid use was reduced ( p= 0.03) in the chitosan group (1,793 mL; 95% CI, 749-4,291) compared with the gauze group (6,614 mL; 95% CI, 2,519-17,363 mL). Survival was seven of eight and two of even in the chitosan and gauze groups ( p= 0.04), respectively. Hemostasis was improved in the chitosan group ( p= 0.03). CONCLUSION: A chitosan dressing reduced hemorrhage and improved survival after severe liver injury in swine. Further studies are warranted.


Subject(s)
Bandages/standards , Chitin/analogs & derivatives , Chitin/therapeutic use , Disease Models, Animal , Hemorrhage/therapy , Hemostatic Techniques/standards , Hemostatics/therapeutic use , Liver/injuries , Animals , Blood Volume , Chitosan , Drug Evaluation, Preclinical , Female , Fluid Therapy/methods , Hemorrhage/diagnosis , Hemorrhage/etiology , Hemorrhage/mortality , Male , Random Allocation , Resuscitation/methods , Survival Analysis , Swine , Time Factors
SELECTION OF CITATIONS
SEARCH DETAIL
...